← Eichor
Condition: Personalized Cancer Treatment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Personalized Cancer Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plu
Phase 1/Phase 2 · 1 location(s) · Yinghua Xu · NCT07495215Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
Phase 2/Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT06336642A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
NA · 1 location(s) · Fudan University · NCT06682117Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06607120GCC 2546- Motion Management
NA · 1 location(s) · University of Maryland, Baltimore · NCT07398209Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05830279ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NA · 3 location(s) · Indiana University · NCT05879913Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT07054086PErsonalized TReatment for Endometrial Carcinoma
NA · 1 location(s) · University of Helsinki · NCT05655260WBSI Guided Personalized Delivery of TTFields
NA · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT05086497ctDNA-MRD Monitoring After Resection in Gastric Cancer
Phase N/A · 1 location(s) · Peking University · NCT06893133APA (Adapted Physical Activity) for Patients With Advanced Melanoma
Phase N/A · 1 location(s) · University Hospital, Rouen · NCT07031830Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
NA · 1 location(s) · University of Chicago · NCT05166694Developing a Comprehensive Exercise Service for Breast Cancer Process
Phase N/A · 1 location(s) · GO fit Lab- Ingesport · NCT07380971Personalized Oncogenomics (POG) Program of British Columbia
NA · 1 location(s) · British Columbia Cancer Agency · NCT02155621Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastati
Phase 2 · 27 location(s) · National Cancer Institute (NCI) · NCT06311214Improving Personalized Treatment in Oncology: Effects of Integrated Oncological Decision-making
NA · 4 location(s) · Leiden University Medical Center · NCT07046884Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
NA · 1 location(s) · Medical University of Vienna · NCT06512311Personalized Medicine for Advanced Biliary Cancer Patients
Phase 3 · 69 location(s) · UNICANCER · NCT05615818Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Canc
Phase 1 · 4 location(s) · Emory University · NCT06324240Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Sub
Phase 1 · 1 location(s) · Sir Run Run Shaw Hospital · NCT06026800Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
Phase 2 · 7 location(s) · Centre Leon Berard · NCT02029001Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
Phase 2/Phase 3 · 1 location(s) · Second Affiliated Hospital of Wenzhou Medical University · NCT06341907Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Per
NA · 7 location(s) · Medical University of Bialystok · NCT05582876Immunotherapy for the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 1 location(s) · Tongji Hospital · NCT03658785Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC
NA · 1 location(s) · Turku University Hospital · NCT04846933Personalized Treatment in Thyroid Disorders
NA · 1 location(s) · Johns Hopkins University · NCT03517579Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NA · 2 location(s) · The First Affiliated Hospital of Nanchang University · NCT06751966Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pa
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06572423Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HS
Phase N/A · 1 location(s) · Ciceri Fabio · NCT05124288
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.